Drug maker Mallinckrodt again files for bankruptcy, as planned

Drug maker Mallinckrodt plc (NYSE: MNK) said Monday that it and certain subsidiaries have filed for Chapter 11 bankruptcy in the U.S. as part of its previously announced restructuring deal with lenders that will cut some $1.9 billion in debt.